Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06244199 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty

Study acronym: T2CR
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 months later Mar 31, 2027 → Dec 31, 2027
See other at-risk trials from VA Office of Research and Development

Record History

  1. Primary completion pushed from Mar 31, 2027 to Dec 31, 2027 Completion pushed from Aug 31, 2027 to Dec 31, 2027 · Eligibility criteria expanded, about 15 words · Secondary endpoints: details revised at 11 of 13 entries · 2 more Show 5 more changesShow less
    • Completion pushed from Aug 31, 2027 to Dec 31, 2027
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 11 of 13 entries
    • Study description revised
    • Site contacts updated at 2 of 2 sites
  2. Site details revised at 1 of 2 sitesv9
  3. Phase: Phase 2 to Not applicablev8
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Sep 1, 2024 to Nov 1, 2024 · Secondary endpoints: 12 to 13 · Site details revised at 2 of 2 sitesv7 Show 3 more changesShow less
    • Start date changed from estimate of Sep 1, 2024 to Nov 1, 2024
    • Secondary endpoints: 12 to 13
    • Site details revised at 2 of 2 sites

    See this version in full on ClinicalTrials.gov ↗

  5. Start date: Aug 26, 2024 to Sep 1, 2024v6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Jul 15, 2024 to Aug 26, 2024v5
  2. Start date: Jun 1, 2024 to Jul 15, 2024 Primary endpoint revised · Secondary endpoints: 13 to 12 · Study description expanded, about 3 wordsv4 Show 3 more changesShow less
    • Primary endpoint revised
    • Secondary endpoints: 13 to 12
    • Study description expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  3. Start date: May 1, 2024 to Jun 1, 2024v3
  4. Start date: Apr 1, 2024 to May 1, 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Cardiac rehabilitation (CR) is a secondary prevention program for patients with cardiovascular disease (CVD). It is especially valuable as CVD increasingly occurs in combination with comorbidity, frailty, and complexities of care that predispose patients to functional decline, disability, and high costs. Still, few Veterans participate in CR, in part because of the difficult logistics to attend. Promising Practice home-based CR (HBCR) was developed to increase CR participation, but many Veterans remain too limited by comorbidity and frailty for participation. A Transition to CR (T2CR) intervention is a face-to-face program that fosters vital skills, education, insights, motivation, and patient-provider relationships conducive to successful HBCR thereafter. This study compares Veterans eligible for CR who are randomized to T2CR intervention versus usual care. Differences in functional capacity, HBCR participation, and healthy days at home are compared over one year. Patients' experiences and providers' perspectives of barriers and facilitators to T2CR are also compared.
Trial Details
NCT Number NCT06244199
Lead Sponsor VA Office of Research and Development
Conditions Cardiovascular Diseases, Cardiac Rehabilitation, Transition of Care
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov